conmed.com - CNMD Company Value to Revenue Ratio

Public company logo of CONMED (CNMD)

Innovative electrosurgical systems and imaging are driving current growth for CONMED Corporation (CNMD), while the value of 1568.48 captures the metric level on the chart. The company's current price-to-sales ratio helps assess the impact of elective surgery volumes and FDA approvals on earnings. The integration of orthopedic devices into operating rooms creates strong clinical loyalty to the brand's ecosystem.

CNMD CONMED Corporation: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

CNMD (CONMED Corp.): analytical breakdowns and indicator data

- money and cash flow information:
Fundamental valuation:CONMED Corporation CNMD
Mass-produced product of CONMED Corp

CONMED Corporation (CNMD) maintains a steady revenue stream driven by its patent-protected equipment portfolio and high customer switching costs. This business resilience is directly reflected in the Enterprise Value to Sales (EV/Sales) ratio. This metric demonstrates the asset's real price by excluding the impact of leverage. By analyzing the current EV/Sales level, an investor can determine the extent of the premium paid for generated revenue, where inflated values signal market optimism and increase the risk of a correction.

Competitor analysis for CONMED Corporation

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue Pulse Biosciences, Inc. PLSE|EV/Sales Multiple INMD (inmodemd.com)|Picard Medical Inc. - Enterprise Value-to-Revenue Ratio|SRDX - Enterprise Value-to-Revenue Ratio|SENS: Enterprise Value-to-Revenue Ratio|NPCE (NeuroPace, Inc.) - Company Value to Revenue|Tactile Systems Technology, Inc. - Business Value to Revenue|SNWV (SANUWAVE Health Inc) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)